USA signs cancer research pact with Cuba

21 October 2016

Cuba and the USA on Thursday signed an agreement to cooperate on cancer research as part of a visit to the island nation by US Secretary of Health and Human Services Sylvia Burwell.

Signed by Ms Burwell and Cuban Minister of Health Roberto Morales, the memorandum of understanding (MoU) involves implementation of joint research projects, meetings, and workshops related to cancer control, in a bid to promote their exchange of information and best practices on the matter, according to the Chinese state news agency Xinhua.

"This agreement on cancer research and control is very important because we know it is a big issue in both countries and we are excited to work together to make progress in this field," said Ms Burwell after signing the accord.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK